How has Avanos Medical's pre-tax stock-based compensation cost changed year-over-year?

Avanos Medical's pre-tax stock-based compensation cost decreased by 2.6% year-over-year, from $3.8M to $3.7M.

What is the long-term trend for Avanos Medical's pre-tax stock-based compensation cost?

Over 4 years (2021 to 2025), Avanos Medical's pre-tax stock-based compensation cost has grown at a -1.2% compound annual growth rate (CAGR), from $13.2M to $12.6M.

Avanos Medical AVNS Pre-tax stock-based compensation cost

Pre-tax stock-based compensation cost at other companies

MedtronicMDT

——

AMN HealthcareAMN

——

CorvelCRVL

——

Henry ScheinHSIC

——

Other financials

Income statement

See full

Revenue$182.2M+8.8%

Gross profit$94.2M+4.9%

Operating income$8.9M-13.6%

Net income$5.1M-22.7%

EPS (diluted)$0.11-21.4%

Balance sheet

See full

Cash & equivalents$65.6M-32.4%

Total debt$138.4M-1.8%

Total equity$782.1M-6.8%

Total assets$1.1B-5.2%

Cash flow

See full

Operating cash flow-$12.3M-148%

CapEx$4.3M-35.8%

Free cash flow-$16.6M-187%

Valuation

See full

Market cap$1.17B+108%

Enterprise value$1.24B+105%

P/S1.6×+0.8×

Profitability

See full

Gross margin50%-4.6pp

Operating margin-9.1%-4.2pp

Net margin-10.4%-4.7pp

FCF margin1.6%-14.9pp

Returns & leverage

See full

Return on equity-9.2%-3.9pp

Debt / equity0.2×0.0×

Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's pre-tax stock-based compensation cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avanos Medical's pre-tax stock-based compensation cost?: Avanos Medical (AVNS) reported pre-tax stock-based compensation cost of $3.7M in Q1 2026.
How has Avanos Medical's pre-tax stock-based compensation cost changed year-over-year?: Avanos Medical's pre-tax stock-based compensation cost decreased by 2.6% year-over-year, from $3.8M to $3.7M.
What is the long-term trend for Avanos Medical's pre-tax stock-based compensation cost?: Over 4 years (2021 to 2025), Avanos Medical's pre-tax stock-based compensation cost has grown at a -1.2% compound annual growth rate (CAGR), from $13.2M to $12.6M.